Centenial Surgical Suture (BSE: CSURGSU) is loss-making over the last 12 months, losing ₹1.43 Cr, so a P/E ratio does not apply. Its share price on 5 Nov 2026 was ₹70.20, 44% below its 52-week high. Sales grew 0.7% a year over 3 years. Debt is 1.06× equity. It is a small-cap company with a market cap of ₹26 Cr; the shares fell 31% over the past year.
- ₹72.66
- ₹73.00
- ₹68.38
- ₹70.20
- 2K
Health check
- ReturnsWeak
−31.4% over the past year.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales +0.7% a year over 3 years, but loss-making now.
- ProfitabilityWeak
ROCE 0.3%.
- Balance sheetFair
Debt 1.06× equity, interest covered 1.9×.
- Red flags4 to check
Loss-making over the last twelve months.
Small cap
Defensive
Key metrics
- Market cap
- ₹26 Cr
- Small cap
- P/E
- n/a
- Price to book
- 0.90
- Book value ₹78.24
- Dividend yield
- 0.00%
- ROE
- −7.4%
- Return on equity
- ROCE
- 0.3%
- Return on capital employed
- Debt to equity
- 1.06
- Debt ₹30 Cr
- EPS (TTM)
- −₹3.96
- OPM (TTM)
- 10.7%
- Net margin −2.5%
- Sales growth
- +18.6%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 0.46
- EV/EBITDA 9.0
Strengths and risks
Strengths
- Quarterly sales up 18.6% on a year ago.
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −7.4%.
- 44% below its 52-week high.
- Interest coverage of only 1.9×.
About Centenial Surgical Suture
Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The…
- Headquarters
- Thane
- Employees
- 266
- Sector
- Healthcare
- ISIN
- INE405H01018
- Website
- centenialindia.com
Price range
- Avg volume (3M)
- 279
- 1-year return
- minus 31.4%
- From 52-week high
- minus 43.8%
Peers
We couldn’t find listed peers for this company.
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 12.9 | 13.5 | 14.9 | 12.6 | 15.3 | |
| 11.7 | 12.1 | 13.3 | 11.6 | 13.2 | |
| 1.2 | 1.4 | 1.5 | 0.9 | 2.2 | |
| 9.5% | 10.4% | 10.3% | 7.4% | 14.2% | |
| 0 | 0 | 0.1 | 0.1 | 0 | |
| 0.3 | 0.5 | 0.3 | 2.2 | 0.3 | |
| 1 | 1 | 1 | 1 | 0.9 | |
| −0 | −0 | 0.2 | −2.2 | 1 | |
| – | – | 25.2% | −3.8% | 25.2% | |
| −0 | −0 | 0.1 | −2.3 | 0.7 | |
| -0.11 | -0.03 | 0.40 | -6.34 | 2.01 |
Profit & loss
- Sales CAGR 3Y
- +0.7%
- ROE
- −7.4%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 52.7 | 51.2 | 53.5 | 53.8 | |
| – | minus 2.8% | +4.5% | +0.6% | |
| 49.2 | 47.6 | 48.7 | 49.7 | |
| 3.5 | 3.6 | 4.8 | 4.1 | |
| 6.6% | 7.0% | 9.0% | 7.7% | |
| 0 | 0 | 0 | −0 | |
| 0.7 | 0.9 | 2.2 | 2.2 | |
| 1.3 | 1.4 | 4.3 | 4 | |
| – | – | – | 0 | |
| 1.5 | 1.3 | −1.6 | −2.1 | |
| 39.4% | 10.9% | 9.5% | −5.8% | |
| 0.9 | 1.1 | −1.5 | −2.2 | |
| – | +28.0% | minus 229.0% | – | |
| 2.43 | 3.11 | -4.01 | -6.04 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 5.4 | 5.4 | 5.4 | 5.4 | |
| 25.7 | 26.8 | 25.3 | 23.1 | |
| 15 | 27.6 | 33.5 | 29.8 | |
| 20.3 | 19.3 | 20.3 | 21.4 | |
| 66.4 | 79.2 | 84.6 | 79.8 | |
| 6.5 | 12.8 | 20 | 18.2 | |
| 0 | 0 | 0 | 0 | |
| 0.3 | 0.7 | 0.2 | 0.2 | |
| 59.6 | 65.7 | 64.4 | 61.4 | |
| 66.4 | 79.2 | 84.6 | 79.8 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1.3 | 6.2 | 17.1 | 7.3 | |
| −0.2 | −7.9 | −11.6 | −2.4 | |
| −1 | 2.1 | −5.9 | −4.9 | |
| 0.1 | 0.4 | −0.5 | −0 | |
| −0.2 | −7.7 | −11.5 | −2.2 | |
| 1.1 | −1.5 | 5.6 | 5.1 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.